Human NGF form comprising two mutations, a first mutation being represented by the substitution of the proline amino acid 61 with serine, a second mutation being represented by the substitution of an aminoacid in any of the positions 95-101, for the simultaneous use as agent for the activation of the chemokine SDF-1alpha and as an agent for the inhibition of the activity of the cytokine TNF alpha

Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases

Capsoni Simona
2017

Abstract

Human NGF form comprising two mutations, a first mutation being represented by the substitution of the proline amino acid 61 with serine, a second mutation being represented by the substitution of an aminoacid in any of the positions 95-101, for the simultaneous use as agent for the activation of the chemokine SDF-1alpha and as an agent for the inhibition of the activity of the cytokine TNF alpha
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11392/2383691
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact